author-photo

Matt McKevitt

7

Papers

109

Citations

Citation Trend

Filter By

Papers (4) Sort By

Journal Conference Others

Andecaliximab [Anti-matrix Metalloproteinase-9] induction therapy for ulcerative colitis: A randomised, double-blind, placebo-controlled, phase 2/3 study in patients with moderate to severe disease

2018 Journal of Crohns & Colitis
Show All
- Source
- Cite
- Save
Citations (19)
A Phase 2, Randomized, Placebo-Controlled Study Evaluating Matrix Metalloproteinase-9 Inhibitor, Andecaliximab, in Patients With Moderately to Severely Active Crohn’s Disease

2018 Journal of Crohns & Colitis
Show All
- Source
- Cite
- Save
Citations (18)
Two phase 3 placebo-controlled trials of aztreonam lysine for inhalation (AZLI) for non-cystic fibrosis bronchiectasis (NCFB)

2013 European Respiratory Journal
Show All
- Source
- Cite
- Save
Citations (16)
Aztreonam For Inhalation Solution (AZLI) Appears To Improve Patient Reported Symptoms Regardless Of The Severity Of Bronchiectasis

2012 ATS | American Thoracic Society International Conference
Show All
- Source
- Cite
- Save
Citations (0)